Back

Oxaliplatin Induces Spontaneous Firing at Sensory Endings Across Touch and Proprioceptive Afferents

Nardelli, P.; Reed, J.; Vincent, J. A.; Vitali, G. A.; Bui, K. C.; Housley, S. N.; Cope, T. C.

2026-07-08 neuroscience
10.64898/2026.07.03.736383 bioRxiv
Show abstract

Spontaneous activity in primary sensory neurons has been implicated in neuropathic symptoms, yet its earliest origins and immediate functional consequences remain incompletely understood. This gap is especially consequential in chemotherapy-induced peripheral neuropathy (CIPN), where sensory toxicities commonly limit effective cancer treatment. Using in vivo recordings in rats, we show that a single dose of oxaliplatin (OX) induces spontaneous firing within 24 h across touch and proprioceptive low-threshold mechanoreceptor (LTMR) afferents. Spontaneous firing consistently originated distally in peripheral axons and was accompanied by enhanced responses to mechanical stimulation, identifying LTMR sensory endings as the earliest source of spontaneous firing and a common site for spontaneous and stimulus-evoked hyperexcitability. OX also induced early structural abnormalities at sensory endings; however, SF+ LTMRs retained mechanosensory response profiles, indicating that spontaneous firing can emerge within otherwise functional sensory endings. Although coincident spontaneous and stimulus-evoked activity distorted encoding in individual LTMRs, these effects had little impact on population LTMR responses or motor behavior relying on mechanosensory feedback. Together, these findings identify sensory endings as an early target of OX neurotoxicity and demonstrate that spontaneous firing spanning multiple tactile and proprioceptive LTMR submodalities can coexist with largely preserved sensory function, indicating that even broad engagement across mechanosensory pathways is insufficient to disrupt all LTMR-dependent functions. These observations indicate that abnormal afferent activity initiated at sensory endings may be sufficient to engage sensory pathways underlying some paresthetic symptoms while leaving others largely unaffected, whereas progression to chronic neuropathic symptoms may require subsequent recruitment of the dorsal root ganglion.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
eLife
5828 papers in training set
Top 6%
12.8%
2
Pain
78 papers in training set
Top 0.3%
7.2%
3
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 6%
6.7%
4
Nature Communications
5641 papers in training set
Top 25%
6.2%
5
The Journal of Neuroscience
1025 papers in training set
Top 3%
6.2%
6
JCI Insight
277 papers in training set
Top 1%
5.5%
7
Scientific Reports
3612 papers in training set
Top 17%
5.4%
50% of probability mass above
8
Cell Reports
1498 papers in training set
Top 7%
5.4%
9
Journal of Neurophysiology
302 papers in training set
Top 0.9%
4.3%
10
eneuro
439 papers in training set
Top 2%
3.2%
11
Brain
168 papers in training set
Top 1%
3.1%
12
Experimental Neurology
61 papers in training set
Top 0.4%
2.6%
13
Frontiers in Cellular Neuroscience
91 papers in training set
Top 0.8%
2.1%
14
Neuroscience
97 papers in training set
Top 0.9%
1.7%
15
Journal of Clinical Investigation
179 papers in training set
Top 3%
1.7%
16
The Journal of Physiology
150 papers in training set
Top 1%
1.7%
17
Science Advances
1243 papers in training set
Top 20%
1.7%
18
Progress in Neurobiology
47 papers in training set
Top 0.4%
1.4%
19
PLOS ONE
5266 papers in training set
Top 53%
1.3%
20
Glia
81 papers in training set
Top 1%
1.1%
21
iScience
1154 papers in training set
Top 35%
0.8%
22
Brain Communications
166 papers in training set
Top 3%
0.8%
23
Advanced Science
286 papers in training set
Top 10%
0.8%
24
Science Translational Medicine
127 papers in training set
Top 4%
0.6%
25
PLOS Biology
486 papers in training set
Top 14%
0.6%
26
Communications Biology
993 papers in training set
Top 35%
0.6%
27
Experimental Physiology
21 papers in training set
Top 0.6%
0.6%
28
Neurobiology of Pain
11 papers in training set
Top 0.2%
0.6%